Nutramax Laboratories, Inc.

David Bledsoe

David Griffin

Todd R Henderson

An anxiolytic composition formulated for oral administration to a mammal includes a synergistic combination of L-theanine, at least one ofand an extract of, and at least one ofand an extract of. The composition may include a combination of an extract ofand a extract of. The synergistic combination may provide an anxiolytic change in a release pattern of one or more brain neurotransmitters, such as glutamate and/or γ-aminobutyric acid (GABA).

Compositions comprising theanine, magnolia, and phellodendron

An anxiolytic composition includes a synergistic combination of one or more of an L-theanine, an s-adenosylmethionine (SAMe), and optionally an extract of, an extract of, and a whey protein.

Compositions comprising theanine, s-adenosylmethionine (SAMe), and/orand

An anxiolytic composition includes a synergistic combination of an L-theanine and a whey protein composition.

Compositions comprising theanine and whey protein

An anxiolytic composition includes a synergistic combination of one or more of an extract of, an extract of, an L-theanine, a whey protein composition, and/or an s-adenosylmethionine (SAMe).

Growing community of inventors

Lancaster, SC, United States of America

David Bledsoe